2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow COVID - 19: new trials by email Literature Review of COVID - 19 trials Research Report on COVID - 19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19 Ratutrelvir (83-0060) non-randomised, Paxlovid, Ratutrelvir (83-0060) - COVID - 19 | Phase 2 | Recruiting | Traws Pharma, Inc. | 90 | 2025-09-16 | 2026-01-21 |
| Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients Remdesivir (RDV) - COVID - 19, Renal Transplant | Phase 2 | Recruiting | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 15 | 2025-09-01 | 2025-09-29 |
COVID-19 (2)
Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2)
nirmatrelvir and ritonavir drug combination (1) · remdesivir (1)
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1) · Traws Pharma, Inc. (1)
Australia (1) · South Korea (1) · Spain (1) · Taiwan (1) · Uzbekistan (1)